Mesa Laboratories Inc. (MLAB)
-NasdaqGM 54.89 
0.64(1.18%) May 17, 4:00PM EDT
| Prev Close: | 54.25 |
|---|
| Open: | 54.05 |
|---|
| Bid: | N/A |
|---|
| Ask: | 64.00 x 100 |
|---|
| 1y Target Est: | 59.00 |
|---|
| Beta: | 0.58 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 53.94 - 55.54 |
|---|
| 52wk Range: | 38.64 - 57.00 |
|---|
| Volume: | 42,466 |
|---|
| Avg Vol (3m): | 12,446 |
|---|
| Market Cap: | 185.47M |
|---|
| P/E (ttm): | 23.88 |
|---|
| EPS (ttm): | 2.30 |
|---|
| Div & Yield: | 0.56 (1.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Mesa Laboratories Enters Oversold Territory (MLAB)at TheStreet(Fri, Apr 19)
- Mesa Labs Declares Quarterly DividendPR Newswire(Wed, Apr 17)
- What Mesa Laboratories's Earnings Headlines Didn't Tell Youat Motley Fool(Tue, Mar 19)
- Why the Street Should Love Mesa Laboratories's Earningsat Motley Fool(Wed, Mar 13)
- Reminder - Mesa Laboratories (MLAB) Goes Ex-Dividend Soonat Forbes(Thu, Feb 21)
- Mesa Laboratories: Growth Strategy Is Workingat Seeking Alpha(Wed, Feb 13)
- MESA LABORATORIES INC /CO FinancialsEDGAR Online Financials(Wed, Feb 13)
- MESA LABORATORIES INC /CO Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, Feb 8)
- Mesa Labs Declares Quarterly DividendPR Newswire(Wed, Feb 6)
- MESA LABORATORIES INC /CO Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Wed, Feb 6)
- Mesa Labs Reports 18% Increase in Third Quarter RevenuesPR Newswire(Tue, Feb 5)
- MESA LABORATORIES INC /CO Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Tue, Dec 18)
- The Zacks Analyst Blog Highlights: Thoratec, HeartWare, Merit Medical, Mesa Laboratories and Cantel MedicalZacks(Thu, Dec 13)
- Thoratec Soars to 52-Week HighZacks(Wed, Dec 12)
- 5 Tech Stocks to Buy for 2013: Astro-Medat TheStreet(Wed, Dec 5)
Key Statistics
| Forward P/E (1 yr): | 22.04 |
|---|
| P/S (ttm): | 4.11 |
|---|
| Ex-Dividend Date: | 22-May-13 |
|---|
Analysts
| Annual EPS Est
(Mar-13)
: | 2.35 |
|---|
| Quarterly EPS Est
(Mar-13)
: | 0.59 |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Mesa Laboratories, Inc. designs, manufactures, and markets instruments and disposable products utilized primarily in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries.
View More